Ronan J. Kelly, MD, MBA
Medical Director, Global Oncology, Johns Hopkins International; Director, Gastro-esophageal Cancer Therapeutics Program, Sidney Kimmel Comprehensive Cancer Center at John Hopkins, Baltimore, Maryland, USA
Dr. Ronan Kelly is the Medical Director of Global Oncology for Johns Hopkins International and the Director of the Gastro-esophageal Cancer Therapeutics Program at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins. As a thoracic oncologist, Dr. Kelly is committed to the understanding of genomic and epigenomic alterations in gastro-esophageal and lung cancers. Dr. Kelly performs translational research encompassing the discovery and the development of new epigenetic, genetic and immunotherapeutic approaches in the detection, diagnosis, prevention and treatment of thoracic malignancies. He is the International Principal Investigator on a number of phase II/III immunotherapy studies in Gastro-esophageal cancer. Dr. Kelly sits on a number of national and international task forces dedicated to improving the quality of cancer care delivered to patients, with an emphasis on increasing value while bending the cost curve downwards. He is the chair of the International Association for the Study of Lung Cancer (IASLC) committee on quality/value and is a member of the American Society of Clinical Oncology (ASCO) taskforces on quality of cancer care and measures subcommittee. He is actively working with Johns Hopkins affiliates throughout the world to improve the quality of cancer care. Dr. Kelly received his initial medical training at the Royal College of Surgeons in Ireland. Subsequently, he earned a Master’s degree in Business Administration from University College Dublin, with a focus on health economics and drug costs. He worked at the National Cancer Institute in Bethesda, Maryland for four years prior to joining Johns Hopkins in 2011.